Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 22250925)

1.

Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.

Dhalla S, Poole G, Singer J, Patrick DM, Kerr T.

Psychol Health Med. 2012;17(2):223-34. doi: 10.1080/13548506.2011.608803. Epub 2012 Jan 17.

2.

Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.

Dhalla S, Poole G, Singer J, Patrick DM, Wood E, Kerr T.

Vaccine. 2010 Feb 17;28(7):1663-7. doi: 10.1016/j.vaccine.2009.12.023. Epub 2009 Dec 29.

PMID:
20044049
3.

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, Willoughby B, Remis R.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):521-8.

PMID:
12473841
4.

Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.

Giocos G, Kagee A, Swartz L.

AIDS Behav. 2008 Nov;12(6):842-51. Epub 2007 Aug 1.

PMID:
17668313
5.

Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.

Otwombe KN, Sikkema KJ, Dietrich J, de Bruyn G, van der Watt M, Gray GE.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):211-8. doi: 10.1097/QAI.0b013e31822b7702.

6.

Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.

Dong Y, Shen X, Guo R, Liu B, Zhu L, Wang J, Zhang L, Sun J, Zhang X, Xu J.

PLoS One. 2014 Nov 5;9(11):e111321. doi: 10.1371/journal.pone.0111321. eCollection 2014.

7.

Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.

Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, Strathdee SA.

AIDS Behav. 2005 Sep;9(3):301-9.

PMID:
16088366
9.

Willingness to participate in HIV vaccine trials: the impact of trial attributes.

Newman PA, Duan N, Lee SJ, Rudy E, Seiden D, Kakinami L, Cunningham W.

Prev Med. 2007 Jun;44(6):554-7. Epub 2006 Dec 24.

10.

Willingness of Chinese injection drug users to participate in HIV vaccine trials.

Yin L, Zhang Y, Qian HZ, Rui B, Zhang L, Zhu J, Guan Y, Wang Y, Li Q, Ruan Y, Shao Y.

Vaccine. 2008 Feb 6;26(6):762-8. doi: 10.1016/j.vaccine.2007.11.091. Epub 2007 Dec 26.

11.

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Aliyu G, Mohammad M, Saidu A, Mondal P, Charurat M, Abimiku A, Nasidi A, Blattner W.

AIDS Care. 2010 Oct;22(10):1277-84. doi: 10.1080/09540121003692219.

12.

Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials.

Mbunda T, Bakari M, Tarimo EA, Sandstrom E, Kulane A.

Glob Health Action. 2014 Feb 25;7:22853. doi: 10.3402/gha.v7.22853. eCollection 2014.

13.

Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.

Evangeli M, Kafaar Z, Kagee A, Swartz L, Bullemor-Day P.

AIDS Care. 2013;25(7):910-4. doi: 10.1080/09540121.2012.748163. Epub 2012 Dec 7.

PMID:
23216424
14.

Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.

Etcheverry MF, de Lazzari E, Fuchs JD, Meroño M, Sierra E, Del Romero J, Evans JL, Mendez-Arancibia E, Jacques C, Rojas D, Segú M, Gatell JM, Joseph J.

AIDS Behav. 2010 Jun;14(3):607-17. doi: 10.1007/s10461-008-9486-x.

PMID:
19037720
15.

Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Asiki G, Abaasa A, Ruzagira E, Kibengo F, Bahemuka U, Mulondo J, Seeley J, Bekker LG, Delany S, Kaleebu P, Kamali A.

Vaccine. 2013 Oct 17;31(44):5055-61. doi: 10.1016/j.vaccine.2013.08.080. Epub 2013 Sep 7.

16.

Who will enroll? Predicting participation in a phase II AIDS vaccine trial.

Halpern SD, Metzger DS, Berlin JA, Ubel PA.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):281-8.

PMID:
11464149
17.

Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?

Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K.

Vaccine. 2010 Aug 23;28(37):5947-51. doi: 10.1016/j.vaccine.2010.07.006. Epub 2010 Jul 16.

18.

Response to Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

Halpern SD.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):412. No abstract available.

PMID:
12843757
19.

Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.

Kiwanuka N, Robb M, Kigozi G, Birx D, Philips J, Wabwire-Mangen F, Wawer MJ, Nalugoda F, Sewankambo NK, Serwadda D, Gray RH.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):721-5.

PMID:
15167291
20.

Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.

Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, Khamboonruang C, Nelson KE.

AIDS. 1995 Sep;9(9):1079-83.

PMID:
8527082
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk